Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Periprocedural Oral Hydration Patterns and Early Renal Function after Coronary Angiography and Intervention: A Prospective Real-World Cohort Study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Karger Country of Publication: Switzerland NLM ID: 101554863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1664-5502 (Electronic) Linking ISSN: 16645502 NLM ISO Abbreviation: Cardiorenal Med Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Basel : Karger
    • الموضوع:
    • نبذة مختصرة :
      Introduction: Guidelines recommend oral hydration (OH) to prevent contrast-associated acute kidney injury (CA-AKI) after coronary angiography or intervention, but quantitative protocols are lacking, and practice varies. Shorter hospital stays limit opportunities for post-procedure creatinine monitoring, and real-world OH patterns and their early renal effects remain poorly described. This study aimed to characterize periprocedural weight-adjusted OH trajectories and to assess whether trajectory membership was associated with a change in serum creatinine within 24 h.
      Methods: This single-center prospective cohort study enrolled 192 inpatients undergoing coronary angiography or intervention between November 2024 and May 2025. We recorded weight-adjusted oral intake in four windows: pre-12 h, post-0-6 h, 6-12 h, and 12-24 h. We computed partial-overlap dynamic time warping distances and clustered trajectories using partitioning around medoids. Group comparisons used nonparametric tests. The primary outcome was percent change in serum creatinine, and dose-response was assessed with generalized additive models (GAMs) adjusted for baseline creatinine, estimated glomerular filtration rate, comorbidities, procedural indication, contrast volume, and intravenous hydration.
      Results: After excluding 18 patients for missing periprocedural oral intake or post-procedure creatinine, 174 patients were analyzed (median age 65.0 years, IQR 57.2 to 72.0; 71.8% male). Median weight-adjusted cumulative oral intake was 10.9, 18.6, 23.9, and 33.3 mL/kg for the pre-12 h, post-0-6 h, 0-12 h, and 0-24 h windows. Time-series clustering produced two stable groups (low-OH n = 85, high-OH n = 89; average silhouette = 0.393; bootstrap adjusted Rand index = 0.845). The largest between-group difference occurred in the 0-6 h window (median 4.12 vs. 2.00 mL/kg/h, p < 0.001). No patient met CA-AKI criteria. In adjusted GAMs, the 0-6 h OH rate was not a significant smooth term (edf = 3.79, p = 0.795), and cluster membership was not associated with creatinine change. However, the high-OH cluster had substantially greater 6-h urine output and a larger positive fluid balance (p < 0.001), while serum potassium was similar between clusters.
      Conclusion: Periprocedural OH was generally ample and formed two reproducible patterns. Concentrating oral intake in the first 6 h increased early urine output and positive fluid balance but did not show a significant dose-response association with early serum creatinine change. This null result should be interpreted cautiously because the cohort was generally low-risk, follow-up was short, and the study had limited power. Future studies should validate whether early concentrated OH protects renal function using earlier sensitive biomarkers and by targeting high-risk patients.
      (© 2025 The Author(s). Published by S. Karger AG, Basel.)
    • References:
      Lancet. 2017 Apr 1;389(10076):1312-1322. (PMID: 28233565)
      Arch Cardiovasc Dis. 2009 Nov;102(11):761-7. (PMID: 19944392)
      Trials. 2019 May 27;20(1):290. (PMID: 31133052)
      Int Heart J. 2019 Mar 20;60(2):247-254. (PMID: 30799374)
      J Am Coll Cardiol. 2016 Sep 27;68(13):1465-1473. (PMID: 27659469)
      Crit Care. 2013 Jan 17;17(1):R7. (PMID: 23327106)
      Interv Cardiol Clin. 2020 Jul;9(3):299-309. (PMID: 32471671)
      BMC Cardiovasc Disord. 2021 Jan 31;21(1):61. (PMID: 33517880)
      J Am Heart Assoc. 2025 May 20;14(10):e038920. (PMID: 40371586)
      Medicine (Baltimore). 2017 Dec;96(50):e8460. (PMID: 29390255)
      Biomark Med. 2010 Apr;4(2):265-80. (PMID: 20406069)
      J Cardiothorac Vasc Anesth. 2019 Oct;33(10):2695-2702. (PMID: 31113711)
      J Am Heart Assoc. 2021 Jul 6;10(13):e021342. (PMID: 34169747)
      N Engl J Med. 2018 Feb 15;378(7):603-614. (PMID: 29130810)
      Cardiorenal Med. 2021;11(5-6):243-251. (PMID: 34823253)
      Eur Radiol. 2024 Apr;34(4):2512-2523. (PMID: 37823923)
      Nephron Clin Pract. 2012;120(4):c179-84. (PMID: 22890468)
      Biomed Res Int. 2014;2014:741018. (PMID: 24895606)
      BMC Nephrol. 2024 Apr 22;25(1):140. (PMID: 38649939)
      J Am Heart Assoc. 2019 Jul 2;8(13):e012131. (PMID: 31498023)
      Nephron Clin Pract. 2014;128(1-2):95-100. (PMID: 25378376)
      Crit Care. 2010;14(3):R82. (PMID: 20459609)
      BMJ. 2009 Jun 29;338:b2393. (PMID: 19564179)
      Angiology. 2025 Aug;76(7):681-689. (PMID: 38339782)
      Circ Cardiovasc Interv. 2015 Sep;8(9):e002673. (PMID: 26333343)
      N Engl J Med. 2019 May 30;380(22):2146-2155. (PMID: 31141635)
      Circulation. 2010 May 18;121(19):2117-22. (PMID: 20439784)
      JACC Cardiovasc Interv. 2019 Oct 14;12(19):1877-1888. (PMID: 31521648)
      J Nephrol. 2018 Dec;31(6):797-812. (PMID: 29802583)
      Cureus. 2022 May 8;14(5):e24825. (PMID: 35693368)
      Can J Cardiol. 2017 Oct;33(10):1225-1228. (PMID: 28941604)
      Acta Cardiol. 2012 Oct;67(5):565-9. (PMID: 23252007)
    • Contributed Indexing:
      Keywords: Contrast-associated acute kidney injury; Coronary angiography and intervention; Oral hydration; Prospective real-world cohort; Time-series clustering
    • الرقم المعرف:
      0 (Contrast Media)
      AYI8EX34EU (Creatinine)
    • الموضوع:
      Date Created: 20251231 Date Completed: 20260204 Latest Revision: 20260206
    • الموضوع:
      20260206
    • الرقم المعرف:
      PMC12872192
    • الرقم المعرف:
      10.1159/000550260
    • الرقم المعرف:
      41474683